Amyloid-β peptide and oligomers in the brain and cerebrospinal fluid of aged canines

Elizabeth Head, Viorela Pop, Floyd Sarsoza, Rakez Kayed, Tina L. Beckett, Christa M. Studzinski, Jennifer L. Tomic, Charles G. Glabe, M. Paul Murphy

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

The study of Alzheimer's disease (AD) pathogenesis requires the use of animal models that develop some amount of amyloid pathology in the brain. Aged canines (beagles) naturally accumulate human-type amyloid-β peptide (Aβ) and develop parallel declines in cognitive function. However, the type and quantity of biochemically extracted Aβ in brain and cerebrospinal fluid (CSF), its link to aging, and similarity to human aging has not been examined systematically. Thirty beagles, aged 4.5-15.7 years, were studied. Aβ{40} and Aβ{42} were measured in CSF by ELISA, and from SDS and formic acid extracted prefrontal cortex. A sample of the contralateral hemisphere, used to assess immunohistochemical amyloid load, was used for comparison. In the brain, increases in Aβ{42} were detected at a younger age, prior to increases in Aβ{40}, and were correlated with an increased amyloid load. In the CSF, Aβ{42} decreased with age while Aβ{40} levels remained constant. The CSF Aβ{42/40} ratio was also a good predictor of the amount of Aβ in the brain. The amount of soluble oligomers in CSF was inversely related to brain extractable Aβ, whereas oligomers in the brain were correlated with SDS soluble Aβ{42}. These findings indicate that the Aβ in the brain of the aged canine exhibits patterns that mirror Aβ deposited in the human brain. These parallels support the idea that the aged canine is a useful intermediate between transgenic mice and humans for studying the development of amyloid pathology and is a potentially useful model for the refinement of therapeutic interventions.

Original languageEnglish (US)
Pages (from-to)637-646
Number of pages10
JournalJournal of Alzheimer's Disease
Volume20
Issue number2
DOIs
StatePublished - 2010

Fingerprint

Amyloid
Cerebrospinal Fluid
Canidae
Peptides
Brain
formic acid
Pathology
Human Development
Prefrontal Cortex
Cognition
Transgenic Mice
Alzheimer Disease
Animal Models
Enzyme-Linked Immunosorbent Assay

Keywords

  • Alzheimer's disease
  • amyloid-β peptide
  • amyloid-β protein precursor
  • beagle
  • cerebrospinal fluid
  • dog
  • oligomer

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Clinical Psychology

Cite this

Head, E., Pop, V., Sarsoza, F., Kayed, R., Beckett, T. L., Studzinski, C. M., ... Murphy, M. P. (2010). Amyloid-β peptide and oligomers in the brain and cerebrospinal fluid of aged canines. Journal of Alzheimer's Disease, 20(2), 637-646. https://doi.org/10.3233/JAD-2010-1397

Amyloid-β peptide and oligomers in the brain and cerebrospinal fluid of aged canines. / Head, Elizabeth; Pop, Viorela; Sarsoza, Floyd; Kayed, Rakez; Beckett, Tina L.; Studzinski, Christa M.; Tomic, Jennifer L.; Glabe, Charles G.; Murphy, M. Paul.

In: Journal of Alzheimer's Disease, Vol. 20, No. 2, 2010, p. 637-646.

Research output: Contribution to journalArticle

Head, E, Pop, V, Sarsoza, F, Kayed, R, Beckett, TL, Studzinski, CM, Tomic, JL, Glabe, CG & Murphy, MP 2010, 'Amyloid-β peptide and oligomers in the brain and cerebrospinal fluid of aged canines', Journal of Alzheimer's Disease, vol. 20, no. 2, pp. 637-646. https://doi.org/10.3233/JAD-2010-1397
Head, Elizabeth ; Pop, Viorela ; Sarsoza, Floyd ; Kayed, Rakez ; Beckett, Tina L. ; Studzinski, Christa M. ; Tomic, Jennifer L. ; Glabe, Charles G. ; Murphy, M. Paul. / Amyloid-β peptide and oligomers in the brain and cerebrospinal fluid of aged canines. In: Journal of Alzheimer's Disease. 2010 ; Vol. 20, No. 2. pp. 637-646.
@article{e78a3bdc092044f29a7e20ce31d9907e,
title = "Amyloid-β peptide and oligomers in the brain and cerebrospinal fluid of aged canines",
abstract = "The study of Alzheimer's disease (AD) pathogenesis requires the use of animal models that develop some amount of amyloid pathology in the brain. Aged canines (beagles) naturally accumulate human-type amyloid-β peptide (Aβ) and develop parallel declines in cognitive function. However, the type and quantity of biochemically extracted Aβ in brain and cerebrospinal fluid (CSF), its link to aging, and similarity to human aging has not been examined systematically. Thirty beagles, aged 4.5-15.7 years, were studied. Aβ{40} and Aβ{42} were measured in CSF by ELISA, and from SDS and formic acid extracted prefrontal cortex. A sample of the contralateral hemisphere, used to assess immunohistochemical amyloid load, was used for comparison. In the brain, increases in Aβ{42} were detected at a younger age, prior to increases in Aβ{40}, and were correlated with an increased amyloid load. In the CSF, Aβ{42} decreased with age while Aβ{40} levels remained constant. The CSF Aβ{42/40} ratio was also a good predictor of the amount of Aβ in the brain. The amount of soluble oligomers in CSF was inversely related to brain extractable Aβ, whereas oligomers in the brain were correlated with SDS soluble Aβ{42}. These findings indicate that the Aβ in the brain of the aged canine exhibits patterns that mirror Aβ deposited in the human brain. These parallels support the idea that the aged canine is a useful intermediate between transgenic mice and humans for studying the development of amyloid pathology and is a potentially useful model for the refinement of therapeutic interventions.",
keywords = "Alzheimer's disease, amyloid-β peptide, amyloid-β protein precursor, beagle, cerebrospinal fluid, dog, oligomer",
author = "Elizabeth Head and Viorela Pop and Floyd Sarsoza and Rakez Kayed and Beckett, {Tina L.} and Studzinski, {Christa M.} and Tomic, {Jennifer L.} and Glabe, {Charles G.} and Murphy, {M. Paul}",
year = "2010",
doi = "10.3233/JAD-2010-1397",
language = "English (US)",
volume = "20",
pages = "637--646",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "2",

}

TY - JOUR

T1 - Amyloid-β peptide and oligomers in the brain and cerebrospinal fluid of aged canines

AU - Head, Elizabeth

AU - Pop, Viorela

AU - Sarsoza, Floyd

AU - Kayed, Rakez

AU - Beckett, Tina L.

AU - Studzinski, Christa M.

AU - Tomic, Jennifer L.

AU - Glabe, Charles G.

AU - Murphy, M. Paul

PY - 2010

Y1 - 2010

N2 - The study of Alzheimer's disease (AD) pathogenesis requires the use of animal models that develop some amount of amyloid pathology in the brain. Aged canines (beagles) naturally accumulate human-type amyloid-β peptide (Aβ) and develop parallel declines in cognitive function. However, the type and quantity of biochemically extracted Aβ in brain and cerebrospinal fluid (CSF), its link to aging, and similarity to human aging has not been examined systematically. Thirty beagles, aged 4.5-15.7 years, were studied. Aβ{40} and Aβ{42} were measured in CSF by ELISA, and from SDS and formic acid extracted prefrontal cortex. A sample of the contralateral hemisphere, used to assess immunohistochemical amyloid load, was used for comparison. In the brain, increases in Aβ{42} were detected at a younger age, prior to increases in Aβ{40}, and were correlated with an increased amyloid load. In the CSF, Aβ{42} decreased with age while Aβ{40} levels remained constant. The CSF Aβ{42/40} ratio was also a good predictor of the amount of Aβ in the brain. The amount of soluble oligomers in CSF was inversely related to brain extractable Aβ, whereas oligomers in the brain were correlated with SDS soluble Aβ{42}. These findings indicate that the Aβ in the brain of the aged canine exhibits patterns that mirror Aβ deposited in the human brain. These parallels support the idea that the aged canine is a useful intermediate between transgenic mice and humans for studying the development of amyloid pathology and is a potentially useful model for the refinement of therapeutic interventions.

AB - The study of Alzheimer's disease (AD) pathogenesis requires the use of animal models that develop some amount of amyloid pathology in the brain. Aged canines (beagles) naturally accumulate human-type amyloid-β peptide (Aβ) and develop parallel declines in cognitive function. However, the type and quantity of biochemically extracted Aβ in brain and cerebrospinal fluid (CSF), its link to aging, and similarity to human aging has not been examined systematically. Thirty beagles, aged 4.5-15.7 years, were studied. Aβ{40} and Aβ{42} were measured in CSF by ELISA, and from SDS and formic acid extracted prefrontal cortex. A sample of the contralateral hemisphere, used to assess immunohistochemical amyloid load, was used for comparison. In the brain, increases in Aβ{42} were detected at a younger age, prior to increases in Aβ{40}, and were correlated with an increased amyloid load. In the CSF, Aβ{42} decreased with age while Aβ{40} levels remained constant. The CSF Aβ{42/40} ratio was also a good predictor of the amount of Aβ in the brain. The amount of soluble oligomers in CSF was inversely related to brain extractable Aβ, whereas oligomers in the brain were correlated with SDS soluble Aβ{42}. These findings indicate that the Aβ in the brain of the aged canine exhibits patterns that mirror Aβ deposited in the human brain. These parallels support the idea that the aged canine is a useful intermediate between transgenic mice and humans for studying the development of amyloid pathology and is a potentially useful model for the refinement of therapeutic interventions.

KW - Alzheimer's disease

KW - amyloid-β peptide

KW - amyloid-β protein precursor

KW - beagle

KW - cerebrospinal fluid

KW - dog

KW - oligomer

UR - http://www.scopus.com/inward/record.url?scp=77954507297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954507297&partnerID=8YFLogxK

U2 - 10.3233/JAD-2010-1397

DO - 10.3233/JAD-2010-1397

M3 - Article

VL - 20

SP - 637

EP - 646

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 2

ER -